Catalyst Pharmaceuticals Inc (CPRX)
Cost of Revenue
$105.52M
TTM · Period ending: · USD
CPRX Cost of Revenue
Latest reported$105.52Mperiod ending
Latest reported$105.52Mperiod ending
CPRX TTM Cost of Revenue ($0.00 → $105.52M)
TTM cost of revenue
High-resolution chart · PNG
CPRX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 105,521,000 | |
| 99,254,000 | |
| 94,823,000 | |
| 88,789,000 | |
| 74,236,000 | |
| 68,845,000 | |
| 63,011,000 | |
| 57,901,000 | |
| 54,541,000 | |
| 51,967,000 | |
| 47,353,000 | |
| 42,851,000 | |
| 38,449,000 | |
| 34,393,000 | |
| 30,546,000 | |
| 26,191,000 | |
| 23,093,000 | |
| 21,884,000 | |
| 19,405,658 | |
| 17,974,658 | |
| 17,569,531 | |
| 17,039,531 | |
| 16,568,138 | |
| 17,076,599 | |
| 17,198,351 | |
| 14,759,139 | |
| 18,777,843 | |
| 18,928,751 | |
| 18,371,950 | |
| 19,919,204 | |
| 14,906,869 | |
| 13,073,423 | |
| 11,820,350 | |
| 11,375,237 | |
| 10,791,257 | |
| 10,580,334 | |
| 10,637,480 | |
| 7,823,551 | |
| 5,002,897 | |
| 2,508,897 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |